412077000: Adrenal hormone agent (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3199501000005112 binyrehormonmiddel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
binyrehormonmiddel	Is a	Adrenal hormone	false	Inferred relationship	Some
binyrehormonmiddel	Is a	Drug allergen	false	Inferred relationship	Some
binyrehormonmiddel	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Adrenal hormone (disposition)	false	Inferred relationship	Some
binyrehormonmiddel	Is a	Hormone	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
binyrebarkmiddel	Is a	False	binyrehormonmiddel	Inferred relationship	Some
Product containing prednisone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing budesonide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing fluticasone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Fluticasone propionate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing fluorometholone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing rimexolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
loteprednoletabonat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing loteprednol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolontebutatpræparat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonhexacetonid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolonnatriumsuccinat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing cortisone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing alclometasone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing clobetasone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
clobetasonbutyrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing deflazacort (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing diflucortolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
diflucortolonvalerat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing fluclorolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluclorolonacetonid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluocinonidpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing fluocortolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluocortoloncaproat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing glucocorticoid (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid med modificeret udløsning 3 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortison 25 mg suppositorium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Hydrocortisone acetate 100 mg/mL rectal foam	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Hydrocortisone acetate 25 mg rectal suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisolone (as prednisolone sodium phosphate) 5 mg rectal suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolon 20 mg/100 ml retentionsklysma med langt rektalrør	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolon 20 mg/100 ml retentionsklysma med standardrektalrør	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Budesonide-containing product in rectal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 2 mg/100 ml klysma	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
kombinationspræparater + kortikosteroider til rektal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Salmeterol+fluticasone propionate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
salmeterol 25 µg + fluticasonpropionat 50 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
salmeterol 25 µg + fluticasonpropionat 125 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
salmeterol 50 µg + fluticasonpropionat 100 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
salmeterol 50 µg + fluticasonpropionat 250 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
salmeterol 50 µg + fluticasonpropionat 0500 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 400 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 400 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 50 µg indåndingsudløst aerosolinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 250 µg indåndingsudløst aerosolinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 100 µg indåndingsudløst aerosolinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 250 µg inhalator + kompakt spacer	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 250 µg kompakt spacer til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 400 µg inhalationspulver, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 100 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 200 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 100 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 200 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 250 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 200 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 50 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 100 µg inhalationspulver, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 200 µg inhalationspulver, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Beclomethasone dipropionate 100 microgram/actuation pressurized solution for inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 200 µg + salbutamol 400 µg inhalationspulver, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 100 µg + salbutamol 200 µg pædiatrisk inhalationspulver, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 50 µg + salbutamol 100 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 100 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 200 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 400 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 500 µg/2 ml inhalationsvæske til nebulisator enkeltdosis	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 1 mg/2 ml nebulisatorampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 200 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 50 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 50 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 100 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 250 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 50 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 100 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 250 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 25 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 50 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 125 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 250 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 500 µg blisterplader + diskhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 500 µg blisterplader til genopfyldning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 50 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 100 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 250 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 500 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 0,5 mg/2 ml nebulisatorampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 2 mg/2 ml nebulisatorampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 125 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 250 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluticasonpropionat 50 µg CFC-fri inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 50 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 100 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 250 µg indåndingsudløst tørpulverinhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
alclometasondipropionatpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
amcinonidpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
betamethasonvaleratpræparat til systemisk anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
betamethasonbenzoatpræparat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonidpræparat til systemisk anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some

Page 1 of 9 Next End

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2467529014	Adrenal hormone agent (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2473681016	Adrenal hormone agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3199501000005112	binyrehormonmiddel	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)